Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Directorate Change

31 May 2018 07:00

RNS Number : 7163P
Allied Minds PLC
31 May 2018
 

Allied Minds appoints Fritz Foley as an Independent Non-Executive Director

 

Directorate Change

Appointment of Independent Non-Executive Director

Boston, MA (31 May 2018) - Allied Minds plc (LSE: ALM) today announces the appointment of Fritz Foley as an Independent Non-Executive Director.

Fritz Foley is the André R. Jakurski Professor and Senior Associate Dean for Strategic Financial Planning at Harvard Business School (HBS) where his research focuses on corporate finance. Prior to joining the HBS faculty in 2004, he taught at the University of Michigan Business School. He has published papers on investment, capital structure, working capital management, dividend policy, joint ventures, intellectual property, and corporate tax policy, and has advised firms in technology, biotech, retail, health care, professional services, and other industries on financial matters and strategic choices. He has also served as a trustee for several nonprofit organizations.

Peter Dolan, Chairman of Allied Minds, commented "We are delighted to welcome Fritz Foley to the Board of Allied Minds. His insights and network as a highly respected corporate finance specialist will be invaluable to the Board."

 

Fritz Foley commented "I look forward to working with the Board and leadership team at Allied Minds and applying my academic experience for the benefit of its subsidiaries as they focus on exploiting the commercial potential of US academic breakthroughs."

 

There are no further details in relation to Mr Foley's appointment which require disclosure pursuant to paragraph 9.6.13 of the Listing Rules of the Financial Conduct Authority.

Mr Foley gained his Ph. D. in Business Economics from Harvard University and his B.A. in Ethics, Politics, and Economics from Yale University.

 

 

ENDS

 

For more information, please contact:

 

Allied Minds plc

Neil Pizey, Head of Corporate Development

+1 617 419 1800

IR@alliedminds.com

FTI Consulting

Ben Atwell / Brett Pollard

+44 20 3727 1000

 

 

About Allied Minds

Allied Minds plc is an IP commercialisation company focused on technology and life sciences. With extensive access to U.S. federal government laboratories and universities, as well as partnerships with leading U.S. corporations, Allied Minds forms, funds, and operates a portfolio of companies with the objective of delivering successful liquidity events that will generate attractive long-term returns for its investors and stakeholders. Allied Minds supports its businesses with capital, resources, and expertise.

 

Allied Minds Forward-Looking Statement

This press release contains statements that are or may be forward-looking statements, including statements that relate to Allied Minds' future prospects, developments and strategies. The forward-looking statements are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risks and uncertainties described in the risk factors included in Allied Minds' regulatory filings. These forward-looking statements are based on assumptions regarding the present and future business strategies of Allied Minds and the environment in which it will operate in the future. Each forward-looking statement speaks only as at the date of this press release. Except as required by law, regulatory requirement, the Listing Rules and the Disclosure Guidance and Transparency Rules, neither Allied Minds nor any other party intends to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAAMMJTMBMJBJP
Date   Source Headline
28th Jan 20224:36 pmRNSPrice Monitoring Extension
26th Jan 20224:41 pmRNSSecond Price Monitoring Extn
26th Jan 20224:36 pmRNSPrice Monitoring Extension
7th Dec 20214:41 pmRNSSecond Price Monitoring Extn
7th Dec 20214:36 pmRNSPrice Monitoring Extension
6th Dec 20214:41 pmRNSSecond Price Monitoring Extn
6th Dec 20214:36 pmRNSPrice Monitoring Extension
24th Nov 20214:40 pmRNSSecond Price Monitoring Extn
24th Nov 20214:35 pmRNSPrice Monitoring Extension
8th Nov 20217:00 amRNSPortfolio company update
1st Nov 20217:00 amRNSDisposal of portfolio company
27th Oct 20214:36 pmRNSPrice Monitoring Extension
22nd Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20217:00 amRNSHalf-year Report
28th Sep 20214:41 pmRNSSecond Price Monitoring Extn
28th Sep 20214:37 pmRNSPrice Monitoring Extension
27th Sep 20214:41 pmRNSSecond Price Monitoring Extn
27th Sep 20214:36 pmRNSPrice Monitoring Extension
23rd Sep 20214:41 pmRNSSecond Price Monitoring Extn
23rd Sep 20214:36 pmRNSPrice Monitoring Extension
23rd Sep 20217:00 amRNSNotice of Results - Update
8th Sep 20214:40 pmRNSSecond Price Monitoring Extn
8th Sep 20214:36 pmRNSPrice Monitoring Extension
8th Sep 20217:00 amRNSNotice of Results
1st Sep 20211:07 pmRNSTotal Voting Rights
25th Aug 20214:41 pmRNSSecond Price Monitoring Extn
25th Aug 20214:35 pmRNSPrice Monitoring Extension
23rd Aug 20214:41 pmRNSSecond Price Monitoring Extn
23rd Aug 20214:36 pmRNSPrice Monitoring Extension
19th Aug 202110:10 amRNSDirector/PDMR Shareholding
19th Aug 202110:09 amRNSDirector/PDMR Shareholding
19th Aug 202110:07 amRNSDirector/PDMR Shareholding
11th Aug 20217:00 amRNSUpdate on portfolio companies
11th Aug 20217:00 amRNSTransaction in Own Shares
9th Aug 20217:00 amRNSTransaction in Own Shares
6th Aug 20217:00 amRNSTransaction in Own Shares
4th Aug 20217:00 amRNSTransaction in Own Shares
3rd Aug 20217:00 amRNSTransaction in Own Shares
2nd Aug 20213:31 pmRNSTotal Voting Rights
2nd Aug 20217:00 amRNSTransaction in Own Shares
30th Jul 20217:00 amRNSTransaction in Own Shares
29th Jul 20217:00 amRNSTransaction in Own Shares
28th Jul 20217:00 amRNSTransaction in Own Shares
27th Jul 20217:00 amRNSTransaction in Own Shares
23rd Jul 20217:00 amRNSTransaction in Own Shares
22nd Jul 20217:00 amRNSTransaction in Own Shares
21st Jul 20217:00 amRNSTransaction in Own Shares
20th Jul 20214:41 pmRNSHolding(s) in Company
20th Jul 20217:00 amRNSTransaction in Own Shares
19th Jul 20217:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.